4th Edition of Global Conference on Gynecology & Women's Health
September 28-30, 2026 | London, UK
Cervical Cancer
Cervical cancer is a type of cancer that develops in the cells of the cervix, which is the lower part of the uterus that opens into the vagina. Most cases of cervical cancer are caused by a virus known as human papillomavirus (HPV). The early stages of cervical cancer often have no symptoms. As the cancer progresses, symptoms may include abnormal vaginal bleeding, pain or discharge. To diagnose cervical cancer, doctors may use a Pap smear test to look for abnormal cells or an HPV test to identify the presence of the HPV virus. Treatment options for cervical cancer depend on the stage and may include surgery, radiation therapy, chemotherapy, or a combination of these treatments. Early detection is key for successful treatment, so regular check-ups with a gynecologist are recommended. Other preventative measures include getting vaccinated against HPV, using condoms, and avoiding smoking.
Neda Zarrin-Khameh
Baylor College of Medicine, United States
Marlen Sulamanidze
Total Charm Clinic, Georgia
Mohamed M Hosni
London North West University Healthcare NHS Trust, United Kingdom
Neda Zarrin-Khameh
Baylor College of Medicine, United States
Marlen Sulamanidze
Total Charm Clinic, Georgia
Mohamed M Hosni
London North West University Healthcare NHS Trust, United Kingdom
Pravin Mhatre
G S Medical college KEM, IndiaSubmit your abstract Today
Title : Evaluate the changes in SP-D levels in plasma during different phases of the menstrual cycle recruited from the Well- Adult Surfactant Protein Study (WASP)
Natnicha Kitti udom, University College London, Thailand
Title : Synergistic antifibrotic potential of protocatechuic acid and D-Carvone in liver protection
Ling Yin, Hefei Comprehensive National Science Center, China
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin-Khameh, Baylor College of Medicine, United States
Title : Non-ablative radiofrequency for pelvic floor dysfunction and female intimate anti-aging: a 6-month prospective multi-centre cohort objectiv
Shaadaiti Wufuer, First Affiliated Hospital of Xinjiang Medical University, China
Title : Benign gynecological conditions and lifetime contraceptive patterns: a population-based analysis of the 2022–2023 national survey of family growth
Mayi Gnofam, Stony Brook University, United States
Title : Hysteroscopic endometrial resection with resectoscope versus Novasure ablation: A look at patient satisfaction with treatment of abnormal uterine bleeding and rates of progression to hysterectomy
Genevieve Kan, West Gippsland Healthcare Group, Australia